Colorectal Cancer Screening:Evaluating Trends & Outcomes

结直肠癌筛查:评估趋势

基本信息

项目摘要

DESCRIPTION (provided by applicant)The proposed research develops microsimulation models to examine the effect of screening as practiced on observed trends in colorectal cancer (CRC) incidence and mortality in a defined population of over 500,000 members of Group Health Cooperative (GHC), a large HMO in western Washington. Extensive information about this population is available from automated clinical data systems that capture multiple health care events, including dates and results of laboratory tests (FOBT) and endoscopy procedures, pharmacy utilization, outpatient physician visits and hospitalizations. An established link between GHC and the westem Washington SEER will be used to identify CRC cases in this defined population and a population-based registry of GI pathology will be used to identify non-malignant outcomes (e.g. advanced adenomas) among GHC members. The proposed research will address 3 primary aims: Aim 1: Develop a microsimulation model for colorectal cancer that describes natural history, screening, diagnosis, and mortality: The model we propose takes distributional functions as inputs for unknown parameters, rather than fixed values. The proposed model has at least four key advantages over previous strategies: 1) The model incorporates uncertainty in model inputs; 2) It allows incorporation of correlation between model parameters through their distributional forms; 3) Its use of distributions as inputs essentially automates sensitivity analyses and offers an important advantage over univariate sensitivity analysis; and 4) The model produces distributional estimates for outputs, quantifying their uncertainty. Aim 2: Model the effect of screening and polypectomy on the trends in CRC incidence and mortality within the Group Health Population aged 50 and older. Our model will use data describing dissemination of screening within this population, allowing us to examine the relationship between screening at GHC and trends in rates. Aim 3: Model the combined effect of HRT, screening and polypectomy on trends in CRC incidence within the female Group Health Population aged 50 and older. HRT has been shown to reduce the incidence and perhaps improve mortality from colorectal cancer. Our third aim will allow us to explore mechanisms for this reduction in risk, such as changes in the risks for adenomatous polyps, decreases in their transition to preclinical cancer, and lengthening of sojourn time.
描述(申请人提供)建议的研究开发微模拟模型,以检验在华盛顿州西部的大型保健组织团体健康合作社(GHC)超过500,000名成员的确定人口中,筛查对结直肠癌(CRC)发病率和死亡率的观察趋势的影响。有关这一群体的广泛信息可从自动化临床数据系统中获得,该系统可捕获多个医疗保健事件,包括实验室测试(FOBT)和内窥镜检查程序的日期和结果、药房利用、门诊医生就诊和住院。GHC和华盛顿SEER西部之间已建立的联系将被用来识别这一定义人群中的CRC病例,基于人群的GI病理登记将被用来识别GHC成员中的非恶性结果(例如晚期腺瘤)。拟议的研究将涉及三个主要目标: 目的1:建立一个描述自然病史、筛查、诊断和死亡率的结直肠癌微观模拟模型:我们提出的模型以分布函数作为未知参数的输入,而不是固定值。与以前的策略相比,该模型至少有四个关键优点:1)该模型包含了模型输入中的不确定性;2)它允许通过模型参数的分布形式包含模型参数之间的相关性;3)它使用分布作为输入基本上自动化了灵敏度分析,并提供了比单变量灵敏度分析更重要的优势;4)该模型产生输出的分布估计,量化其不确定性。 目的2:模拟筛查和息肉切除术对50岁及以上健康人群中结直肠癌发病率和死亡率趋势的影响。我们的模型将使用描述筛查在这一人群中传播的数据,使我们能够检查GHC筛查与发病率趋势之间的关系。 目的3:模拟激素替代疗法、筛查和息肉切除术对50岁及以上女性健康人群中结直肠癌发病率趋势的联合影响。HRT已被证明可以降低结直肠癌的发病率,甚至可能提高死亡率。我们的第三个目标将使我们能够探索降低风险的机制,例如腺瘤性息肉风险的变化,向临床前癌症过渡的减少,以及逗留时间的延长。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CAROLYN M RUTTER其他文献

CAROLYN M RUTTER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CAROLYN M RUTTER', 18)}}的其他基金

Health and Financial Costs of Unequal Care: Colorectal Cancer as a Case Study
不平等护理的健康和财务成本:结直肠癌案例研究
  • 批准号:
    10656807
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
BIOSTATISTICS
生物统计学
  • 批准号:
    8555320
  • 财政年份:
    2011
  • 资助金额:
    $ 27.38万
  • 项目类别:
Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)
研究结直肠癌筛查策略的有效性 (SuCCESS)
  • 批准号:
    8533836
  • 财政年份:
    2011
  • 资助金额:
    $ 27.38万
  • 项目类别:
Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)
研究结直肠癌筛查策略的有效性 (SuCCESS)
  • 批准号:
    8221760
  • 财政年份:
    2011
  • 资助金额:
    $ 27.38万
  • 项目类别:
Modeling the Long-term Comparative Effectiveness of CRC Screening
CRC 筛查的长期比较有效性建模
  • 批准号:
    8555318
  • 财政年份:
    2011
  • 资助金额:
    $ 27.38万
  • 项目类别:
CORES
核心
  • 批准号:
    8555319
  • 财政年份:
    2011
  • 资助金额:
    $ 27.38万
  • 项目类别:
Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)
研究结直肠癌筛查策略的有效性 (SuCCESS)
  • 批准号:
    8335410
  • 财政年份:
    2011
  • 资助金额:
    $ 27.38万
  • 项目类别:
Assessing the Impact of Colorectal Cancer Screening
评估结直肠癌筛查的影响
  • 批准号:
    7912381
  • 财政年份:
    2009
  • 资助金额:
    $ 27.38万
  • 项目类别:
Colorectal Cancer Screening:Evaluating Trends & Outcomes
结直肠癌筛查:评估趋势
  • 批准号:
    6645390
  • 财政年份:
    2002
  • 资助金额:
    $ 27.38万
  • 项目类别:
Colorectal Cancer Screening:Evaluating Trends & Outcomes
结直肠癌筛查:评估趋势
  • 批准号:
    6545239
  • 财政年份:
    2002
  • 资助金额:
    $ 27.38万
  • 项目类别:

相似海外基金

Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
  • 批准号:
    10805177
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
  • 批准号:
    10719777
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
Assessment of a Radiomics-Based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules
基于放射组学的计算机辅助诊断工具对肺结节癌症风险分层的评估
  • 批准号:
    10644765
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
Understanding Breast Cancer Risk and Screening in Transgender Persons through a Pilot Breast Cancer Screening Program
通过乳腺癌筛查试点计划了解跨性别者的乳腺癌风险和筛查
  • 批准号:
    10738974
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett's Esophagus using TissueCypher: The SCRiBE study
使用 TissueCypher 对非发育性巴雷特食管患者的癌症风险进行分层:SCRiBE 研究
  • 批准号:
    10561001
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
An integrative omics approach to investigate gene-environment interaction in colorectal cancer risk
研究结直肠癌风险中基因与环境相互作用的综合组学方法
  • 批准号:
    10668779
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
Efficient and cost-effective breast cancer risk stratification using whole slide histopathology images
使用全玻片组织病理学图像进行高效且经济的乳腺癌风险分层
  • 批准号:
    10649978
  • 财政年份:
    2023
  • 资助金额:
    $ 27.38万
  • 项目类别:
Oral Dysplasia and Oral Cavity Cancer Risk in Dental and Medical Surveillance Settings Using a Chairside Chip-Based Cytopathology Tool
使用基于椅旁芯片的细胞病理学工具评估牙科和医疗监测环境中的口腔发育不良和口腔癌风险
  • 批准号:
    10344966
  • 财政年份:
    2022
  • 资助金额:
    $ 27.38万
  • 项目类别:
Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk
推进特定良性乳腺诊断与未来乳腺癌风险之间关联的证据
  • 批准号:
    10654561
  • 财政年份:
    2022
  • 资助金额:
    $ 27.38万
  • 项目类别:
'Two-Step Authentication' for Optimal Prostate Cancer Risk Determination: An "Extracellular Vesicle"-Based Liquid Biopsy Followed by Multi-Parametric MRI.
用于最佳前列腺癌风险确定的“两步验证”:基于“细胞外囊泡”的液体活检,随后进行多参数 MRI。
  • 批准号:
    462401
  • 财政年份:
    2022
  • 资助金额:
    $ 27.38万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了